36. 表皮水疱症 Epidermolysis bullosa Clinical trials / Disease details

臨床試験数 : 163 / 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04177498 (ClinicalTrials.gov)	August 24, 2021	7/11/2019	Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC	A Pilot, Open Study to Assess Efficacy and Safety of Rigosertib in Patients With Recessive Dystrophi ...	Recessive Dystrophic Epidermolysis Bullosa	Drug: Rigosertib Sodium;Other: Quality-of-Life Assessment	Thomas Jefferson University	Onconova Therapeutics, Inc.	Recruiting	18 Years	79 Years	All	6	Early Phase 1	United States

First Previous1Next Last